Akshay Vaishnaw

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
7 years
Director since
2023

7 years of board service in total across 3 boards, counting each seat separately. Longest: Editas Medicine Inc., 3 years.

3 years · Since 2023
Scholar Rock Holding Corporation Director · President of R&D
3 years · Since 2023
6 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Apr 16, 2026 Scholar Rock Holding Corporation Open-market sale −12,246 $49.57 $607,034
Feb 9, 2026 Scholar Rock Holding Corporation Grant or award +47,021 — —
Jan 13, 2026 Scholar Rock Holding Corporation Open-market sale −20,438 $42.70 $872,703
May 29, 2025 Scholar Rock Holding Corporation Open-market sale −5,130 $29.63 $152,002
May 29, 2025 Scholar Rock Holding Corporation Open-market sale −1,620 $30.01 $48,616
Apr 27, 2025 Scholar Rock Holding Corporation Grant or award +100,000 — —
Apr 27, 2025 Scholar Rock Holding Corporation Grant or award +500,000 — —
Jun 27, 2024 Scholar Rock Holding Corporation Grant or award +13,500 — —
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −771 $184.70 $142,404
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −1,869 $185.54 $346,774
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −1,107 $186.39 $206,334
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −101 $187.37 $18,924
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −17 $188.40 $3,203
Aug 4, 2023 Alnylam Pharmaceuticals Inc. Open-market sale −192 $189.31 $36,348
Aug 3, 2023 Alnylam Pharmaceuticals Inc. Grant or award +5,082 — —

Questions about Akshay Vaishnaw

What boards is Akshay Vaishnaw on?

Akshay Vaishnaw sits on the boards of Editas Medicine Inc., Hemab Therapeutics Holdings Inc. and Scholar Rock Holding Corporation.

How long has Akshay Vaishnaw served on boards?

Our records show at least 7 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.